Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis.
Newell
E L
EL
Jain
S
S
Stephens
C
C
Martland
G
G
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000494:pharmacology; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017514:Pityriasis Lichenoides / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab